ALDX vs BDX · $112.2M cap vs P/E 34, rev $21.84B
Aldeyra The (ALDX) versus Becton Dickinson and Company (BDX) — a side-by-side from cached financials, not a winner call.
Aldeyra The (ALDX) is a biotechnology company listed on US.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
ALDX does not have a complete income-statement cache yet.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
ALDX currently screens at market cap $112.2M. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Not investment advice. Open the ALDX and BDX stock pages for the full models.
Not investment advice.